Shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Get Free Report) reached a new 52-week low during trading on Monday . The stock traded as low as $25.26 and last traded at $25.33, with a volume of 13677440 shares trading hands. The stock had previously closed at $25.84.
Analysts Set New Price Targets
KDP has been the subject of a number of recent research reports. Wells Fargo & Company reduced their target price on shares of Keurig Dr Pepper from $40.00 to $33.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. BNP Paribas cut shares of Keurig Dr Pepper from a "neutral" rating to an "underperform" rating in a research report on Monday, September 22nd. JPMorgan Chase & Co. reduced their target price on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th. Jefferies Financial Group set a $41.00 price objective on shares of Keurig Dr Pepper in a report on Monday, August 25th. Finally, HSBC reissued a "hold" rating and issued a $30.00 price objective (down previously from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday, August 26th. Ten analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $35.14.
Get Our Latest Stock Analysis on Keurig Dr Pepper
Keurig Dr Pepper Trading Down 2.1%
The company has a debt-to-equity ratio of 0.56, a current ratio of 0.64 and a quick ratio of 0.40. The company has a market cap of $34.37 billion, a PE ratio of 22.59, a price-to-earnings-growth ratio of 1.42 and a beta of 0.43. The company's 50 day simple moving average is $30.16 and its two-hundred day simple moving average is $32.51.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The company had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. During the same quarter last year, the firm posted $0.45 earnings per share. Keurig Dr Pepper's revenue was up 6.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Keurig Dr Pepper, Inc will post 1.92 EPS for the current fiscal year.
Keurig Dr Pepper Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a $0.23 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.92 annualized dividend and a yield of 3.6%. Keurig Dr Pepper's dividend payout ratio (DPR) is 82.14%.
Insider Activity at Keurig Dr Pepper
In other Keurig Dr Pepper news, Director Robert James Gamgort sold 7,601 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $35.91, for a total transaction of $272,951.91. Following the sale, the director owned 2,284,568 shares of the company's stock, valued at approximately $82,038,836.88. This trade represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mary Beth Denooyer sold 12,000 shares of the firm's stock in a transaction that occurred on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the sale, the insider directly owned 82,511 shares in the company, valued at approximately $2,777,320.26. The trade was a 12.70% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 435,601 shares of company stock worth $14,421,512. 1.00% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Keurig Dr Pepper
Hedge funds have recently modified their holdings of the business. Amundi grew its position in Keurig Dr Pepper by 7.7% in the 1st quarter. Amundi now owns 4,404,145 shares of the company's stock valued at $156,920,000 after buying an additional 315,290 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its position in Keurig Dr Pepper by 61.8% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 60,630 shares of the company's stock valued at $2,075,000 after buying an additional 23,167 shares during the last quarter. LBP AM SA grew its position in Keurig Dr Pepper by 1,772.6% in the 2nd quarter. LBP AM SA now owns 549,178 shares of the company's stock valued at $18,156,000 after buying an additional 519,851 shares during the last quarter. State of Alaska Department of Revenue grew its position in Keurig Dr Pepper by 9.0% in the 2nd quarter. State of Alaska Department of Revenue now owns 152,411 shares of the company's stock valued at $5,038,000 after buying an additional 12,530 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its position in Keurig Dr Pepper by 51.8% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 33,510 shares of the company's stock valued at $1,154,000 after buying an additional 11,435 shares during the last quarter. 93.99% of the stock is currently owned by hedge funds and other institutional investors.
About Keurig Dr Pepper
(
Get Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report